Trial Profile
Activity with ibrutinib in mantle cell lymphoma patients with central nervous system relapse.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Nov 2015
Price :
$35
*
At a glance
- Drugs Ibrutinib (Primary)
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
- 18 Nov 2015 New trial record